Skip Nav Destination
Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status
Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961
Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation
Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance
Impaired Toll-like receptor 8–mediated IL-6 and TNF-α production in antigen-presenting cells from patients with X-linked agammaglobulinemia
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus–associated lymphoid malignancies
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease
Issue Archive
March 15 2007
In this Issue
Table of Contents
INSIDE BLOOD
EDITORIALS
PLENARY PAPERS
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy, Jr,Fenghuang Zhan,Bart E. Burington,Yongsheng Huang,Simona Colla,Ichiro Hanamura,James P. Stewart,Bob Kordsmeier,Christopher Randolph,David R. Williams,Yan Xiao,Hongwei Xu,Joshua Epstein,Elias Anaissie,Somashekar G. Krishna,Michele Cottler-Fox,Klaus Hollmig,Abid Mohiuddin,Mauricio Pineda-Roman,Guido Tricot,Frits van Rhee,Jeffrey Sawyer,Yazan Alsayed,Ronald Walker,Maurizio Zangari,John Crowley,Bart Barlogie
REVIEW ARTICLES
ERRATUM
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB–regulated antiapoptotic and cell survival gene products in human multiple myeloma cells
Anjana Bhardwaj,Gautam Sethi,Saroj Vadhan-Raj,,Carlos Bueso-Ramos,Yasunari Takada,Upasna Gaur,Asha S. Nair,Shishir Shishodia,Bharat B. Aggarwal
CLINICAL TRIALS AND OBSERVATIONS
Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy
Clinical Trials & Observations
Andreas Hochhaus,Hagop M. Kantarjian,Michele Baccarani,Jeffrey H. Lipton,Jane F. Apperley,Brian J. Druker,Thierry Facon,Stuart L. Goldberg,Francisco Cervantes,Dietger Niederwieser,Richard T. Silver,Richard M. Stone,Timothy P. Hughes,Martin C. Muller,Rana Ezzeddine,Athena M. Countouriotis,Neil P. Shah
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status
Clinical Trials & Observations
Alessandra Carobbio,Guido Finazzi,Vittoria Guerini,Orietta Spinelli,Federica Delaini,Roberto Marchioli,Giovanna Borrelli,Alessandro Rambaldi,Tiziano Barbui
Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961
Clinical Trials & Observations
Draga Barbaric,Todd A. Alonzo,Robert B. Gerbing,Soheil Meshinchi,Nyla A. Heerema,Dorothy R. Barnard,Beverly J. Lange,William G. Woods,Robert J. Arceci,Franklin O. Smith
Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation
Clinical Trials & Observations
Brief Report
Roland Meisel,Lisa Kuypers,Uta Dirksen,Ralf Schubert,Bernd Gruhn,Gabriele Strauss,Karin Beutel,Andreas H. Groll,Ulrich Duffner,Renate Blütters-Sawatzki,Wolfgang Holter,Tobias Feuchtinger,Hans-Peter Grüttner,Horst Schroten,Stefan Zielen,Christian Ohmann,Hans-Jürgen Laws,Dagmar Dilloo,for the Impfung von Kindern nach allogener Stammzelltransplantation (IKAST) Study Group
Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)
Clinical Trials & Observations
Brief Report
Anthony V. Moorman,Susan M. Richards,Hazel M. Robinson,Jon C. Strefford,Brenda E. S. Gibson,Sally E. Kinsey,Tim O. B. Eden,Ajay J. Vora,Christopher D. Mitchell,Christine J. Harrison,on behalf of the UK Medical Research Council (MRC)/National Cancer Research Institute (NCRI) Childhood Leukaemia Working Party (CLWP)
GENE THERAPY
HEMATOPOIESIS
RhoH is important for positive thymocyte selection and T-cell receptor signaling
Tatjana Dorn,Ursula Kuhn,Gerd Bungartz,Sebastian Stiller,Martina Bauer,Joachim Ellwart,Thorsten Peters,Karin Scharffetter-Kochanek,Monika Semmrich,Melanie Laschinger,Bernhard Holzmann,Wolfgang E. F. Klinkert,Per Thor Straten,Tania Køllgaard,Michael Sixt,Cord Brakebusch
α4-Integrin+ endothelium derived from primate embryonic stem cells generates primitive and definitive hematopoietic cells
Gen Shinoda,Katsutsugu Umeda,Toshio Heike,Masato Arai,Akira Niwa,Feng Ma,Hirofumi Suemori,Hong Yuan Luo,David H. K. Chui,Ryuzo Torii,Masabumi Shibuya,Norio Nakatsuji,Tatsutoshi Nakahata
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels
Carina J. M. van Schooten,Cécile V. Denis,Ton Lisman,Jeroen C. J. Eikenboom,Frank W. Leebeek,Jenny Goudemand,Edith Fressinaud,H. Marijke van den Berg,Philip G. de Groot,Peter J. Lenting
Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome
María Victoria Ramos,Gabriela C. Fernández,Natasha Patey,Pablo Schierloh,Ramón Exeni,Irene Grimoldi,Graciela Vallejo,Christian Elías-Costa,Maria del Carmen Sasiain,Howard Trachtman,Christophe Combadière,François Proulx,Marina S. Palermo
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera
Clinical Trials & Observations
Raffaele Landolfi,Leonardo Di Gennaro,Tiziano Barbui,Valerio De Stefano,Guido Finazzi,RosaMaria Marfisi,Gianni Tognoni,Roberto Marchioli,for the European Collaboration on Low-Dose Aspirin in Polycythemia Vera (ECLAP)
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance
Clinical Trials & Observations
Brief Report
Ronen Loebstein,Ilana Dvoskin,Hillel Halkin,Manuela Vecsler,Aharon Lubetsky,Gideon Rechavi,Ninette Amariglio,Yoram Cohen,Gie Ken-Dror,Shlomo Almog,Eva Gak
IMMUNOBIOLOGY
Hlx homeobox transcription factor negatively regulates interferon-γ production in monokine-activated natural killer cells
Brian Becknell,Tiffany L. Hughes,Aharon G. Freud,Bradley W. Blaser,Jianhua Yu,Rossana Trotta,Hsiaoyin C. Mao,Marie L. Caligiuri de Jesús,Mohamad Alghothani,Don M. Benson, Jr,Amy Lehman,David Jarjoura,Danilo Perrotti,Michael D. Bates,Michael A. Caligiuri
Impaired Toll-like receptor 8–mediated IL-6 and TNF-α production in antigen-presenting cells from patients with X-linked agammaglobulinemia
Clinical Trials & Observations
Brief Report
Klára Sochorová,Rudolf Horváth,Daniela Rožková,Jiří Litzman,Jiřina Bartůňková,Anna Šedivá,Radek Špíšek
NEOPLASIA
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus–associated lymphoid malignancies
Clinical Trials & Observations
Susan P. Perrine,Olivier Hermine,Trudy Small,Felipe Suarez,Richard O'Reilly,Farid Boulad,Joyce Fingeroth,Melissa Askin,Arthur Levy,Steven J. Mentzer,Massimo Di Nicola,Alessandro M. Gianni,Christoph Klein,Steven Horwitz,Douglas V. Faller
Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells
Amanda Dutton,Ciaran B. Woodman,Marilyn B. Chukwuma,James I. K. Last,Wenbin Wei,Martina Vockerodt,Karl R. N. Baumforth,Joanne R. Flavell,Martin Rowe,A. Malcolm R. Taylor,Lawrence S. Young,Paul G. Murray
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study
Clinical Trials & Observations
Brief Report
Asher A. Chanan-Khan,Jonathan L. Kaufman,Jayesh Mehta,Paul G. Richardson,Kena C. Miller,Sagar Lonial,Nikhil C. Munshi,Robert Schlossman,Joseph Tariman,Seema Singhal
RED CELLS
STEM CELLS IN HEMATOLOGY
In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells
Xabier L. Aranguren,Aernout Luttun,Carlos Clavel,Cristina Moreno,Gloria Abizanda,Miguel A. Barajas,Beatriz Pelacho,Maialen Uriz,Miriam Araña,Ana Echavarri,Mario Soriano,Enrique J. Andreu,Juana Merino,Jose Manuel Garcia-Verdugo,Catherine M. Verfaillie,Felipe Prósper
TRANSPLANTATION
Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used
Yvonne Loh,Yu Oyama,Laisvyde Statkute,Kathleen Quigley,Kimberly Yaung,Elizabeth Gonda,Walter Barr,Borko Jovanovic,Robert Craig,Dusan Stefoski,Bruce Cohen,Richard K. Burt
A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease
Clinical Trials & Observations
Margaret L. MacMillan,Daniel Couriel,Daniel J. Weisdorf,Gisela Schwab,Nancy Havrilla,Thomas R. Fleming,Saling Huang,Lorin Roskos,Shimon Slavin,Richard K. Shadduck,John DiPersio,Mary Territo,Steve Pavletic,Charles Linker,Helen E. Heslop,H. Joachim Deeg,Bruce R. Blazar
CORRESPONDENCE
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement
Email alerts
Advertisement